Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer. - Wikidata - awgldk - TriplyDB

Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer.

Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer.

http://www.wikidata.org/entity/Q33350682

about

CD133 expression and the prognosis of colorectal cancer: a systematic review and meta-analysis The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions Gelsolin induces colorectal tumor cell invasion via modulation of the urokinase-type plasminogen activator cascade GLUT1 gene is a potential hypoxic marker in colorectal cancer patients.Co-detection of members of the urokinase plasminogen activator system in tumour tissue and serum correlates with a poor prognosis for soft-tissue sarcoma patients Cathepsin B expression and survival in colon cancer: implications for molecular detection of neoplasia.Differential expression of colon cancer associated transcript1 (CCAT1) along the colonic adenoma-carcinoma sequence.Plasma cathepsin L: a prognostic marker for pancreatic cancer Overexpression of EMMPRIN isoform 2 is associated with head and neck cancer metastasis Detection of intestinal cancer by local, topical application of a quenched fluorescence probe for cysteine cathepsins.Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease.Expression of lncRNA-CCAT1, E-cadherin and N-cadherin in colorectal cancer and its clinical significance A Higher Frequency of CD14+ CD169+ Monocytes/Macrophages in Patients with Colorectal Cancer.Circulating and tumor-infiltrating mucosal associated invariant T (MAIT) cells in colorectal cancer patients.Protein Microarrays for Quantitative Detection of PAI-1 in Serum.Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer.Plasma signature of neurological disease in the monogenetic disorder Niemann-Pick Type C.The role of inflammation and proteinases in tumor progression.Involvement of urokinase-type plasminogen activator system in cancer: an overview.Impact of proteolytic enzymes in colorectal cancer development and progression.Loss of E-cadherin expression predicts disease recurrence and shorter survival in colorectal carcinoma.Quantitative expression and localization of cysteine and aspartic proteases in human abdominal aortic aneurysms.Analysis of colorectal cancer glyco-secretome identifies laminin β-1 (LAMB1) as a potential serological biomarker for colorectal cancer.Tissue inhibitor of matrix metalloproteinase-1 expression in colorectal cancer liver metastases is associated with vascular structures.Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients.Molecular characterization of the cathepsin B of turbot (Scophthalmus maximus).Quantitation of putative colorectal cancer biomarker candidates in serum extracellular vesicles by targeted proteomics.The behavior of matrix metalloproteinase-9 in lymphocytic colitis, collagenous colitis and ulcerative colitis.Validity and clinical impact of glucose transporter 1 expression in colorectal cancer.Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications.Prognostic Role of Carcinoembryonic Antigen is Influenced by Microsatellite Instability Genotype and Stage in Locally Advanced Colorectal Cancers The Impact of Matrix Metalloproteinases and Their Tissue Inhibitors in Inflammatory Bowel Diseases Association of Epithelial Mesenchymal Transition with prostate and breast health disparities

P2860

Q26827628-826981C2-DC01-45A1-B688-E53B196E7DD4 Q27004958-3D4551AA-234D-4F80-872B-53D37E977ACF Q28238665-41B21B4F-A975-4D3E-8816-054A8CDB714B Q31087874-B8745907-6F40-4183-A91F-B02803FC3548 Q33484365-BD3DACD0-F569-43CD-804B-DD7780781EEE Q33723658-C147AB05-AB9F-4B6C-A91D-263084E618E9 Q34292820-37D059F0-4BB3-4D66-8E8C-2D21C7918604 Q34339927-0EB16CD0-B7CF-4AB7-8433-858CC1D5388E Q34696906-1C4049F2-1CD0-45D9-B7C2-4005F492B74F Q35140115-6A2D41CF-F07B-44FB-B82F-FDF99C4C031B Q35159273-D3D17BF3-A0DD-449B-BC79-D68F801C6253 Q35584190-3DB04E0A-E645-4190-A5AA-87E689417A9A Q35643683-7654AEDD-63CA-4568-A076-E1F7ABCD53ED Q35824444-1773F268-3397-4854-8001-37A65F90CB4B Q36536034-F331A4BC-AE39-440E-ACE6-C2773140FCC5 Q36563164-F1748A20-F908-4D7B-AA8C-CAA77AEA4B55 Q37538598-A656199B-CAD8-42CA-A810-B7BC4E577537 Q37653212-762ED73B-24A8-4E0A-BC2D-D4DF0A486D5D Q38020728-C2073A13-11F9-4C62-A1E5-005989040781 Q38189275-89860A92-57FA-410A-9FA3-2FC14F97FCF5 Q38259533-8F706014-F2FF-4DF0-9367-C0C0A2DDA097 Q38402754-32ED5816-9058-4A7C-B69B-7EEB533AD25C Q38589689-544B0928-CAF1-42FB-B0CC-D5EA229ECA23 Q38836105-40754562-ADC1-484B-936A-5FD9CBB1FB4C Q38919372-04C21CE1-F6D0-487F-ACF3-32BED9A1BFF6 Q39456710-A53E9B2C-1F80-40E6-B0A3-CAC643FDFC01 Q41696667-401113BA-187B-47C0-BAE4-480E23F1BC9E Q42371873-B48CF5C2-96FC-47DC-9049-476645A19F51 Q45967926-492037EE-0562-476A-A99C-AD04B6A73EA7 Q50074585-EE15B1D9-1151-4A42-9335-581F07EBF61B Q54960825-3256194F-287A-4C39-8BC8-82C22630E88E Q57258028-EBBF1B70-3570-4018-9E0C-FA261197F8B4 Q58427369-331C6819-A8C7-4304-BD9C-C0386C8D76D9 Q58756554-E088F311-2F7F-41AA-8E2E-259FFBAE1292

P2860

Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer.

http://www.wikidata.org/entity/Q33350682

description

2008 nî lūn-bûn

@nan

2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Tumor marker utility and progn ...... CA 19-9 in colorectal cancer.

@ast

Tumor marker utility and progn ...... CA 19-9 in colorectal cancer.

@en

type

label

Tumor marker utility and progn ...... CA 19-9 in colorectal cancer.

@ast

Tumor marker utility and progn ...... CA 19-9 in colorectal cancer.

@en

prefLabel

Tumor marker utility and progn ...... CA 19-9 in colorectal cancer.

@ast

Tumor marker utility and progn ...... CA 19-9 in colorectal cancer.

@en

P1433

Q33350682-ADB99758-2DB6-4708-8ABD-5F7089E3CC87

P1476

Q33350682-44AF3F68-EF17-4EB4-817F-C13A015F2D21

P2093

Q33350682-4EFBACBA-459F-4D3B-8C61-FD1B1F7473ED

Q33350682-7568F416-C725-4DB7-B575-558C9A1C302E

Q33350682-8349D1C3-5CEB-45EF-BD19-4CD70C01BAE1

Q33350682-98ED36AB-09F9-4560-8E2A-3C4C01A4ABB1

Q33350682-A2BEDD3A-8058-476C-8529-B9432065AF85

Q33350682-A3CE6644-923A-4697-85AC-6E7085243293

Q33350682-A8CEBF73-14A9-426A-BE42-40E336763F6E

Q33350682-ADAE2A1C-139C-4E1F-9CE5-337ED8684BCE

P2860

Q33350682-0175E59E-D42E-4D80-8B42-4A66DA41319D

Q33350682-021BE8E4-F6B1-44F4-B73C-60DD0685F320

Q33350682-02FFDAB2-1986-48ED-82D6-2ABCBF38EB76

Q33350682-060328F4-E4D0-4C5D-A95D-83A4F9DBC4E5

Q33350682-1301664F-6352-4947-A6C4-EDB06DD91460

Q33350682-16713744-6C63-488E-963F-C64B820A6543

Q33350682-1B4976B3-3049-47E0-B712-1B9DD32F9EF1

Q33350682-1C773DE4-EC7C-484E-B794-8D0DD8D428C5

Q33350682-20DBAB78-3970-47B1-9262-A2C9E107C9D3

Q33350682-2418E88B-CC3E-45E6-AFD9-CD3288E08C4D

P2888

Q33350682-FB44E47A-D734-4648-8ABD-FF9BED108980

P304

Q33350682-22C00B25-E5B8-4833-9DB7-2AA45241CF22

P31

Q33350682-1295ED53-7303-4A84-A83D-6BD2DC543797

P356

Q33350682-46261CEA-D250-41A1-8D59-7064354E4677

P407

Q33350682-2BEB6ACE-222E-455A-8352-88970070222A

P478

Q33350682-11DC001B-27E4-44DD-AD14-3176CB3EF0E7

P50

Q33350682-126A912D-6F20-439D-B757-DFE7CD679B92

Q33350682-D70415BA-3EA8-4938-B638-0B8E585A4EE2

P577

Q33350682-66256F50-B39A-448E-8E89-86785523413C

P5875

Q33350682-1B9F60B4-9E03-47A3-99A0-CF169A075D71

P6179

Q33350682-7A08EE9C-4904-435D-BB0C-D47E9807115E

P698

Q33350682-7DEDC74F-1D03-491B-BC56-7CBB9219AD79

P921

Q33350682-C77C92D2-F11A-48D2-8758-7656F9E6C0D7

P932

Q33350682-0CA67765-A3B9-4575-BD45-97F1E469CD99

P356

1471-2407-8-194

P1433

P1476

Tumor marker utility and progn ...... d CA 19-9 in colorectal cancer

@en

P2093

Fabio Farinati

http://www.w3.org/2001/XMLSchema#string

Gábor István

http://www.w3.org/2001/XMLSchema#string

László D Molnár

http://www.w3.org/2001/XMLSchema#string

László Herszényi

http://www.w3.org/2001/XMLSchema#string

Mario Plebani

http://www.w3.org/2001/XMLSchema#string

Massimo De Paoli

http://www.w3.org/2001/XMLSchema#string

Romilda Cardin

http://www.w3.org/2001/XMLSchema#string

Zsolt Tulassay

http://www.w3.org/2001/XMLSchema#string

P2860

Serum HCG beta, CA 72-4 and CEA are independent prognostic factors in colorectal cancer

ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer

Cathepsin B and cystatins: evidence for a role in cancer progression

Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer

Prognostic value of plasminogen activator inhibitor-1 in head and neck squamous cell carcinoma.

Should carcinoembryonic antigen be used in the management of patients with colorectal cancer?

Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis.

Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?

Prognostic factors of young patients with colon cancer after surgery.

Plasminogen activators in normal tissue and carcinomas of the human oesophagus and stomach

P2888

1471-2407-8-194

P304

194

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-8-194

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-07-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5235471

http://www.w3.org/2001/XMLSchema#string

P6179

1052756316

http://www.w3.org/2001/XMLSchema#string

P698

18616803

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

2474636

http://www.w3.org/2001/XMLSchema#string